Michel Goldman

Insulin Needs after CD3-Antibody Therapy in New-Onset Type 1 Diabetes

Bart Keymeulen, Evy Vandemeulebroucke, Anette G. Ziegler et al. · New England Journal of Medicine · 2005 · 1.1K citations · Full text

Interleukin 10 reduces the release of tumor necrosis factor and prevents lethality in experimental endotoxemia.

Catherine Gérard, Catherine Bruyns, Arnaud Marchant et al. · The Journal of Experimental Medicine · 1993 · 800 citations · Full text

U Il-10, Immunotoxicology, Immune Regulation +23

Development of a cross-platform biomarker signature to detect renal transplant tolerance in humans

Pervinder Sagoo, Esperanza Perucha, Birgit Sawitzki et al. · Journal of Clinical Investigation · 2010 · 515 citations · Full text

Cross-platform Biomarker Signature, Immune Tolerance, Transplant Recipients +27

Bacterial lipopolysaccharide stimulates the production of cytokines and the expression of costimulatory molecules by human peripheral blood dendritic cells: evidence for a soluble CD14-dependent pathway

Valérie Verhasselt, Christel Buelens, Fabienne Willems et al. · The Journal of Immunology · 1997 · 427 citations · Full text

Role of interleukin‐4 and interleukin‐10 in murine collagen‐induced arthritis. Protective effect of interleukin‐4 and interleukin‐10 treatment on cartilage destruction

Leo A. B. Joosten, Erik Lubberts, Patrick Durez et al. · Arthritis & Rheumatism · 1997 · 399 citations